Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Modell

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
International Journal of Clinical Practice|January 8, 2009
Efficacy and tolerability of ready-to-use intravenous paracetamol solution as monotherapy or as an adjunct analgesic therapy for postoperative pain in patients undergoing elective ambulatory surgery: open, prospective studyT S Göröcs, M Lambert, T Rinne, et al.
Journal of Psychiatric Research|October 28, 1998
Elevated response of growth hormone to graded doses of apomorphine in schizophrenic patientsF Müller-Spahn, S Modell, M Ackenheil, et al.
Behavioural Neurology|February 6, 2004
Involuntary vocalisations and a complex hyperkinetic movement disorder following left side thalamic haemorrhageT Dietl, D P Auer, S Modell, et al.
Journal of Psychiatric Research|December 9, 1998
The Munich vulnerability study on affective disorders: overview of the cross-sectional observations at index investigationC J Lauer, W Schreiber, S Modell, et al.
Journal of Affective Disorders|February 15, 2001
Neuroendocrine, polysomnographic and psychometric observations in healthy subjects at high familial risk for affective disorders: the current state of the 'Munich vulnerability study'J C Krieg, C J Lauer, W Schreiber, et al.
Der Nervenarzt|August 26, 1998
[The Munich Vulnerability Study of Affective Disorders. Overview of the results at index study]C J Lauer, W Schreiber, S Modell, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 24, 1998
Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disordersS Modell, C J Lauer, W Schreiber, et al.
Journal of Affective Disorders|January 8, 1999
The pre-morbid psychometric profile is stable over time in subjects at high familial risk for affective disordersC J Lauer, D von Zerssen, W Schreiber, et al.
Psychological Medicine|February 24, 2005
Impaired divided attention predicts delayed response and risk to relapse in subjects with depressive disordersM Majer, M Ising, H Künzel, et al.
Pharmacopsychiatry|May 20, 2009
Switching to aripiprazole in outpatients with schizophrenia experiencing insufficient efficacy and/or safety/tolerability issues with risperidone: a randomized, multicentre, open-label studyV Ryckmans, J P Kahn, S Modell, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Clinical Practice|January 8, 2009
Efficacy and tolerability of ready-to-use intravenous paracetamol solution as monotherapy or as an adjunct analgesic therapy for postoperative pain in patients undergoing elective ambulatory surgery: open, prospective studyT S Göröcs, M Lambert, T Rinne, et al.
Journal of Psychiatric Research|October 28, 1998
Elevated response of growth hormone to graded doses of apomorphine in schizophrenic patientsF Müller-Spahn, S Modell, M Ackenheil, et al.
Behavioural Neurology|February 6, 2004
Involuntary vocalisations and a complex hyperkinetic movement disorder following left side thalamic haemorrhageT Dietl, D P Auer, S Modell, et al.
Journal of Psychiatric Research|December 9, 1998
The Munich vulnerability study on affective disorders: overview of the cross-sectional observations at index investigationC J Lauer, W Schreiber, S Modell, et al.
Journal of Affective Disorders|February 15, 2001
Neuroendocrine, polysomnographic and psychometric observations in healthy subjects at high familial risk for affective disorders: the current state of the 'Munich vulnerability study'J C Krieg, C J Lauer, W Schreiber, et al.
Der Nervenarzt|August 26, 1998
[The Munich Vulnerability Study of Affective Disorders. Overview of the results at index study]C J Lauer, W Schreiber, S Modell, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 24, 1998
Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disordersS Modell, C J Lauer, W Schreiber, et al.
Journal of Affective Disorders|January 8, 1999
The pre-morbid psychometric profile is stable over time in subjects at high familial risk for affective disordersC J Lauer, D von Zerssen, W Schreiber, et al.
Psychological Medicine|February 24, 2005
Impaired divided attention predicts delayed response and risk to relapse in subjects with depressive disordersM Majer, M Ising, H Künzel, et al.
Pharmacopsychiatry|May 20, 2009
Switching to aripiprazole in outpatients with schizophrenia experiencing insufficient efficacy and/or safety/tolerability issues with risperidone: a randomized, multicentre, open-label studyV Ryckmans, J P Kahn, S Modell, et al.
Pageof 3